RVVTF (Revive Therapeutics) Accounts Payable : $1.90 Mil (As of Sep. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Revive Therapeutics Accounts Payable?

Revive Therapeutics's Accounts Payable for the quarter that ended in Sep. 2024 was $1.90 Mil.

Revive Therapeutics's quarterly Accounts Payable increased from Mar. 2024 ($1.88 Mil) to Jun. 2024 ($1.88 Mil) and increased from Jun. 2024 ($1.88 Mil) to Sep. 2024 ($1.90 Mil).

Revive Therapeutics's annual Accounts Payable declined from Jun. 2022 ($3.06 Mil) to Jun. 2023 ($2.00 Mil) and declined from Jun. 2023 ($2.00 Mil) to Jun. 2024 ($1.88 Mil).

Revive Therapeutics Accounts Payable Historical Data

The historical data trend for Revive Therapeutics's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Revive Therapeutics Accounts Payable Chart

Revive Therapeutics Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Accounts Payable

Get a 7-Day Free Trial

0.16

0.36

3.06

2.00

1.88

Revive Therapeutics Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Accounts Payable	Get a 7-Day Free Trial															1.94	1.86	1.88	1.88	1.90

Revive Therapeutics Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Revive Therapeutics Accounts Payable Related Terms

Thank you for viewing the detailed overview of Revive Therapeutics's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Revive Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Revive Therapeutics Ltd (OTCPK:RVVTF) » Definitions » Accounts Payable

Comparable Companies

Traded in Other Exchanges

31R:Germany RVV:Canada

Address

82 Richmond Street East, The Canadian Venture Building, Toronto, ON, CAN, M5C 1P1

Website

https://www.revivethera.com

Revive Therapeutics Ltd is focused on the research, development, and commercialization of novel psychedelic and cannabinoid-based life sciences products and drug repurposing for infectious diseases. The firm's technology is being developed to fill the medical needs for diseases and disorders such as pain, inflammation, and wound care. Currently, the Company is exploring the use of Bucillamine for the potential treatment of public health medical emergencies and rare inflammatory disorders. Revive is also advancing the development of Psilocybin-based therapeutics through various program.